RB
Revati Bhaskar Sadhu
About Revati Bhaskar Sadhu
Data last updated:
Revati Bhaskar Sadhu is an Additional Director at Accuro Healthcare Private Limited (since 2024) and Director at First Blue Chemicals Private Limited (since 2022). The companies operate in Trading and Food And Beverages. The largest current company by reported revenue is Accuro Healthcare Private Limited at ₹2.11 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Accuro Healthcare Private Limited U51909MH2022PTC377047 | Additional Director | 24 Feb 2024 | 2022 | ₹2.11 Cr (FY 2024) | Active |
| First Blue Chemicals Private Limited U24302MH2022PTC392470 | Director | 20 Oct 2022 | 2022 | Active |
Board colleagues of Revati Bhaskar Sadhu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aniket Digamber Lokmanwar | 09510366 | Accuro Healthcare Private Limited | Director |
| Bhakti Dnyaneshwar Sadhu | 09771142 | First Blue Chemicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Revati Bhaskar Sadhu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Revati Bhaskar Sadhu
Revati Bhaskar Sadhu currently holds 2 directorships: Accuro Healthcare Private Limited (Additional Director, since 24 Feb 2024, revenue ₹2.11 Cr (FY 2024)); First Blue Chemicals Private Limited (Director, since 20 Oct 2022).
Revati Bhaskar Sadhu was first appointed on 20 Oct 2022 as Director at First Blue Chemicals Private Limited. The most recent appointment on record is 24 Feb 2024 at Accuro Healthcare Private Limited.
The current boards of Revati Bhaskar Sadhu's companies include Aniket Digamber Lokmanwar (Accuro Healthcare Private Limited), Bhakti Dnyaneshwar Sadhu (First Blue Chemicals Private Limited).